ArticleMolecular medicine (Cambridge, Mass.)2025

Integrating advanced analytical methods to assess epigenetic marks affecting response to hypomethylating agents in higher risk myelodysplastic syndrome.

Theodoros Nikolopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.